Burnout Is About Your Workplace, Not Your People
Leaders create the conditions that lead to burnout — or prevent it.
Related Articles
America Just Kinda, Sorta Banned Cigarettes
A new rule by the FDA could change smoking as we know it.
Molecular testing in lung cancer explained in 1 slide by a thoracic pathologist
What molecular tests are needed in lung cancer? Which tumors need to be tested? How is the testing done? This video attempt to explain these…
Podcast: What Challenges Will Oncologists Face in 2025?
Dr. Nathan Pennell and Dr. John Sweetenham discuss the evolving landscape of oncology in 2025 and the challenges oncologists will be facing, including the impact…
Podcast: What Challenges Will Oncologists Face in 2025?
Dr. Nathan Pennell and Dr. John Sweetenham discuss the evolving landscape of oncology in 2025 and the challenges oncologists will be facing, including the impact…
How to Keep Up With Molecular Testing and Targeted Therapies in Lung Cancer | JCO Oncology Practice
Until the early 2000s, advanced or metastatic non–small cell lung cancer (NSCLC) was treated as a single disease with all histologic subtypes treated alike with…
Expect Higher Costs for Your Health Care Benefits Next Year
Employers are predicting an increase of as much as 9 percent, on average, but are generally avoiding passing along much of that to their employees,…
9 tips for choosing a Medicare prescription drug plan
Medicare Part D is complex and can come with pitfalls — most significantly, plan terms and costs that may change every year.
Nate Pennell’s fundraising page for VeloSano
100% for the cure! Riding for my mom and all my patients living with cancer.
Nate Pennell’s fundraising page for VeloSano
100% for the cure! Riding for my mom and all my patients living with cancer.
Outcomes for Pembrolizumab Stratified by Pemetrexed Maintenance Post Pembrolizumab–Platinum–Pemetrexed Induction in Metastatic Non-Small-Cell Lung Cancer
Aim: We assessed treatment patterns and outcomes in patients with metastatic nonsquamous non-small-cell lung cancer (mNSCLC) who initiated first-line pembrolizumab–platinum–pemetrexed (induction) …